"Purine Nucleosides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES.
Descriptor ID |
D011684
|
MeSH Number(s) |
D03.633.100.759.590 D13.570.583
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Purine Nucleosides".
Below are MeSH descriptors whose meaning is more specific than "Purine Nucleosides".
This graph shows the total number of publications written about "Purine Nucleosides" by people in this website by year, and whether "Purine Nucleosides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 1 | 2 |
1998 | 0 | 1 | 1 |
2000 | 3 | 0 | 3 |
2001 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
2003 | 1 | 0 | 1 |
2005 | 0 | 1 | 1 |
2006 | 2 | 2 | 4 |
2007 | 1 | 2 | 3 |
2010 | 3 | 0 | 3 |
2013 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Purine Nucleosides" by people in Profiles.
-
Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of Clostridioides difficile. Antimicrob Agents Chemother. 2024 Mar 06; 68(3):e0162123.
-
Quantitation of Purine in Urine by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry. Methods Mol Biol. 2022; 2546:421-430.
-
Purine metabolism regulates DNA repair and therapy resistance in glioblastoma. Nat Commun. 2020 07 30; 11(1):3811.
-
Forodesine in the treatment of cutaneous T-cell lymphoma. Expert Opin Investig Drugs. 2017 Jun; 26(6):771-775.
-
Preclinical and clinical evaluation of forodesine in pediatric and adult B-cell acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk. 2013 Aug; 13(4):458-66.
-
Forodesine: review of preclinical and clinical data. Future Oncol. 2010 Aug; 6(8):1211-7.
-
Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells. Blood. 2010 Aug 19; 116(7):1083-91.
-
Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia. Blood. 2010 Aug 12; 116(6):886-92.
-
Pharmacology and mechanism of action of forodesine, a T-cell targeted agent. Semin Oncol. 2007 Dec; 34(6 Suppl 5):S8-12.
-
Mycosis fungoides: pathophysiology and emerging therapies. Semin Oncol. 2007 Dec; 34(6 Suppl 5):S21-8.